Author

Yimeng Zhang

h-index 0 View on Semantic Scholar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Identification of glycolysis- and myocardial fibrosis-related diagnostic biomarkers in heart failure: an integrative bioinformatics and machine learning study

Five key genes associated with glycolysis and myocardial fibrosis in HF are identified and a robust diagnostic model with excellent predictive performance is constructed, providing novel insights into the molecular mechanisms of HF and offer promising candidates for diagnostic biomarker development and therapeutic targ...

Lin Yang, Bing Liu, Shuang Qiu et al. · Frontiers in Cardiovascular... · 0 citations

Aug 2026

The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD.

In patients with ultrahigh-risk ASCVD, evolocumab was more effective than ezetimibe in promoting coronary plaque regression and the importance of targeting sd-LDL to reduce residual cardiovascular risk is underscored.

Xiao-Ping Li, Lin Yang, X. Zhou et al. · Journal of Clinical Lipidolo... · 0 citations